Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B (Q83512698)
Jump to navigation
Jump to search
scientific article published on 24 February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B |
scientific article published on 24 February 2012 |
Statements
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B (English)
Jens M Kittner
Martin F Sprinzl
Annette Grambihler
Peter R Galle
Marcus Schuchmann
24 February 2012